Biometrics partner for sponsors and CROs

Answering an FDA information request on a ten-day deadline

During review of a new drug application, the agency asked for additional safety analyses by subgroup. We delivered validated datasets and outputs within the deadline.

1

The challenge

Midway through the review, FDA sent an information request asking for treatment-emergent adverse event summaries by new subgroups, using a definition that did not exist in the submitted ADaM datasets. The response was due in ten working days, and the original programming vendor no longer had a team on the study.

2

What we did

We restored the archived submission environment and confirmed we could reproduce the submitted outputs exactly before touching anything. With the sponsor's statistician we agreed the subgroup definition in writing on day one, then added the new flags to ADSL and ADAE through the specification rather than in a one-off program. Every new table was independently double-programmed, and we updated define.xml and the ADRG to describe the new variables.

3

The result

The sponsor submitted its response on time, with outputs that matched the original submission wherever they overlapped. Because the new derivations were built into the ADaM datasets, follow-up questions later in the review were answered in days rather than starting from scratch.

Have a study that needs statistical support?

Tell us about the study and what you need. A statistician will get back to you.